Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Alcon Inc. - ACL

Levi & Korsinsky is investigating the Board of Directors of Alcon Inc. ("Alcon” or the "Company”) (NYSE: ACL) for possible breaches of fiduciary duty and other violations of state law arising out of the announcement by Novartis AG ("Novartis”) (NYSE: NVS) that it has exercised its right to acquire Nestle S.A.’s ("Nestle”) stake in Alcon for $180 per share in cash, or a total of $28.1 billion, giving it an overall ownership interest in Alcon of approximately 77%, and its intent to pay 2.8 of its own shares for each remaining Alcon share held by the public, equivalent to about $11.2 billion. The investigation concerns whether the Alcon Board of Directors breached their fiduciary duties to Alcon shareholders and whether the Alcon minority shareholders are being harmed by as a result of the proposed transaction.

If you own common stock in Alcon and wish to obtain additional information, please contact us at the number listed below or visit http://www.zlk.com/acl1.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation.